Navigation Links
IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer
Date:3/24/2009

LANSDALE, Pa., March 24 /PRNewswire/ --- As the Food and Drug Administration (FDA) approves new cancer fighting drugs for the market, researchers often study their use for non-approved, or off-label, treatments. When the studies show promise for combating other forms of cancer, physicians may prescribe these drugs to patients. By some estimates, nearly 20 percent of all drugs prescribed in the United States are for off-label use. Oncologists prescribe cancer drugs off-label about 60 percent of the time.

"Researchers continually explore the effectiveness of off-label drugs on cancer, which changes the boundaries of the standard of care," said Joyce Muller, president of NAIRO, a national trade organization of independent review organizations (IROs). "Because cancer drugs are often expensive, off-label use requires that health plans look closely at whether these drugs meet plan language for patient reimbursement or are investigational or experimental."

What is Off-label Use?

The FDA approves a drug for a specific treatment and considers any other use "off-label." Because applying for FDA approval is expensive, it often doesn't make financial sense for the drug manufacturer to pursue multiple uses. Although the use of many drugs off-label has been thoroughly researched and often considered the standard of care, this doesn't mean the FDA approves their off-label use.

A few promising cancer drugs are approved by the FDA for multiple use, including Avastin, Revlimid, Imatinib and Erbitux. For example, the agency initially approved Avastin for metastatic colorectal cancer. Then later it approved the drug for non-small cell lung cancer (2006) and breast cancer (2008). Used off-label, however, some doctors see Avastin as a "miracle drug" and may prescribe it for treating other cancers, including prostate, renal cell, head and neck, pancreatic, ovarian and hepatocellular.

Dete
'/>"/>

SOURCE NAIRO
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Genetics Should Decide Warfarin Dose, Study Reiterates
2. Trying to Decide? Forget the Facts and Phone a Friend
3. Genes May Decide Which Smokers Get Lung Disease
4. Popular or Not? Your Genes May Help Decide
5. Decide for Me When I Cant, Most People Say
6. Undecided Voters Not So Undecided After All
7. CSHL neuroscientists glimpse how the brain decides what to believe
8. Which Candidate Has the Perfect Smile, Senator Obama or McCain? TransMedia Group to Publicize Special Election So Florida Voters Can Decide
9. Democrat Mike Turner Backs Single-Payer Healthcare; Opponent Feder Undecided
10. Men Can Take Their Time to Decide on Prostate Cancer Treatment, Reports the Harvard Mens Health Watch
11. Who Decides How to Save Your Life?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Lighthouse Payment Services Inc ., ... it will exhibit its image-based lockbox services at the ... convention in beautiful Lake Placid, New York from ... be held at the Lake Placid Convention Center and ... options in addition to a variety of vendors exhibiting ...
(Date:8/27/2014)... CT (PRWEB) August 27, 2014 Do brands ... International is about to shed some light on the topic ... to members of the Brand Activation Association and ... marketing company polled hundreds of consumers to learn what types ... biggest impact on influencing a potential buying decision. While the ...
(Date:8/27/2014)... Beginning in September, K9 Dog Park ... an interactive, fun way for daycare dogs to learn and ... Dog Park Doggy Daycare clients who bring their dogs into ... Clients will be able to watch their dogs compete through ... compete in D.O.G. will win prizes as will the trainers ...
(Date:8/27/2014)... one of the leading purveyors of real and synthetic hair wigs, ... all its products, for the coming Labor Day. , People searching ... hair products in two ways: when they spend more than ... code LABOR10; while when they spend more than $299, they can ... coupon code is needed when securely checkout, there are about 50 ...
(Date:8/27/2014)... They say knowledge is power, and a new UCLA study ... to men making the best decisions about how to treat ... aren,t well educated about their disease have a much more ... that could negatively impact the quality of their care and ... wake-up call for physicians, who can use the findings to ...
Breaking Medicine News(10 mins):Health News:CRN Set To Release Poll Results On What Marketing Tactics Prompt Consumers To Buy 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3
... you take to lower cholesterol may help protect against ... followed more than 7,500 women ages 65 years and ... study show more than 3 percent of women who ... 2.1 percent of women who used statin cholesterol-lowering drugs ...
... in a migraine medication study who cheated and took the ... a big favor.// ,A new study shows the medication ... rather than waiting until pain is moderate to severe, as ... on the use of drugs known as serotonin agonists for ...
... answer when it comes to children losing weight. The study ... may actually promote weight gain.,// ,Obesity is a serious ... United States. During the past two decades, the prevalence of ... percent. Dieting to lose weight is common among adolescent girls ...
... protect them against severe strains of the bacterium Streptococcus ... according to a new study.,// ,Researchers from Harvard ... in 16 diverse communities throughout Massachusetts. Results of the ... strain of S. pneumoniae -- a bacterium that causes ...
... options, but new research shows there may be a way to ... among men in the United States -- affecting nearly 200,000 men ... outlived all his family members. "My mom died at 56. My ... brother at 58, and my next one at 67," he tells ...
... the importance of weight control throughout life to control ... low socio-economic status during childhood can also contribute to ... suggested the negative effect of birthweight on systolic blood ... age. Researchers from Royal Free and University College of ...
Cached Medicine News:
(Date:8/26/2014)... , Aug. 27, 2014 Higher ... insurance are fuelling the demand for medical devices ... rise of medical tourism, the inflow of patients ... The market will continue its steady ascent as ... age-related and non-communicable diseases, compelling significant investments in ...
(Date:8/26/2014)... plc (NYSE: ACT ), a leading global specialty ... and President of Actavis, will provide an overview and update ... Conference 2014 in New York, NY . ... presentation will take place on Tuesday, September 9, 2014 at ... 109 East 42 nd Street, New York, ...
(Date:8/26/2014)... -- Research and Markets  has announced the addition ... report to their offering. Intranasal drug ... administration of drugs for the treatment of local diseases ... and non-allergic rhinitis and sinusitis. The nose is considered ... and systematic drug delivery. Continuous technological ...
Breaking Medicine Technology:Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 2Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 4Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3
... Inc. (Nasdaq: BNVI ) announced today the publication ... of tamoxifen on estrogen receptor beta (ERb) gene regulation. ... in Molecular and Cellular Endocrinology, demonstrate that tamoxifen inhibits ... breast cancer cell proliferation. , "Tamoxifen has been ...
... , BEIJING, Oct. 20 /PRNewswire-Asia-FirstCall/ ... "the Company") a leading manufacturer, developer,and distributor of Shengmingsu ... of China (PRC), today announced that the Company consummated,the ... of October,16, 2009. , Yongye ...
Cached Medicine Technology:Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta 2Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta 3Yongye International Announces Completion of Restructuring 2Yongye International Announces Completion of Restructuring 3
... with ease of use make the OM-5 ... Ideal for office or hospital-based urodynamics, the ... cystometry, leak point pressure, or urethral pressure ... make the OM-5 flexible enough to meet ...
Windows-Based Urodynamics for Fast and Straightforward. Testing For Clinics Where Logic and Efficiency are at a Premium...
... The Corkscrew FT II (fully threaded) ... anchor designed to be inserted flush with ... strength and anchor stability. The full thread ... suture anchors with protruding eyelets. Especially advantageous ...
... (fully threaded) is a 5.5 mm diameter ... flush with the cortical bone surface to ... fully threaded design substantially improves pull-out strength ... The fully threaded design prevents anchor pull-back ...
Medicine Products: